The Clorox Company
CLX
$148.45
-$1.31-0.88%
| Weiss Ratings | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B | |||
| Rating Factors | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.21 | |||
| Price History | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.47% | |||
| 30-Day Total Return | -5.77% | |||
| 60-Day Total Return | -11.88% | |||
| 90-Day Total Return | -5.94% | |||
| Year to Date Total Return | -7.57% | |||
| 1-Year Total Return | 1.84% | |||
| 2-Year Total Return | 4.20% | |||
| 3-Year Total Return | 12.49% | |||
| 5-Year Total Return | -1.04% | |||
| 52-Week High % Change | -12.61% | |||
| 52-Week Low % Change | 17.37% | |||
| Price | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $171.37 | |||
| 52-Week Low Price | $127.60 | |||
| 52-Week Low Price (Date) | May 29, 2024 | |||
| 52-Week High Price (Date) | Dec 06, 2024 | |||
| Valuation | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 18.45B | |||
| Enterprise Value | 21.41B | |||
| Price/Earnings (TTM) | 40.96 | |||
| Earnings Per Share (TTM) | 3.66 | |||
| Earnings Per Share Growth | 487.33% | |||
| Price/Earnings To Growth | 0.08 | |||
| Price/Sales (TTM) | 2.61 | |||
| Price/Book (Q) | -449.86 | |||
| Enterprise Value/Revenue (TTM) | 2.99 | |||
| Price | $148.44 | |||
| Enterprise Value/EBITDA (TTM) | 17.10 | |||
| Enterprise Value/EBIT | 20.63 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 124.66M | |||
| Dividend Yield | 3.25% | |||
| Div. Per Share (Most Recent) | $1.22 | |||
| Dividend Per Share (TTM) | $4.86 | |||
| Payout Ratio (TTM) | 131.07% | |||
| Dividend Per Share (Most Recent) | $1.22 | |||
| Company Info | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 271 7000 | |||
| Address | 1221 Broadway Oakland, CA 94612-1888 | |||
| Website | www.thecloroxcompany.com | |||
| Country | United States | |||
| Year Founded | 1913 | |||
| Profitability | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.48% | |||
| Profit Margin | 6.37% | |||
| Management Effectiveness | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 11.30% | |||
| Return on Equity | 276.11% | |||
| Income Statement | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 7.17B | |||
| Total Revenue (TTM) | 7.17B | |||
| Revenue Per Share | $57.48 | |||
| Gross Profit (TTM) | 3.19B | |||
| EBITDA (TTM) | 1.25B | |||
| EBIT (TTM) | 1.04B | |||
| Net Income (TTM) | 457.00M | |||
| Net Income Avl. to Common (TTM) | 457.00M | |||
| Total Revenue Growth (Q YOY) | -15.28% | |||
| Earnings Growth (Q YOY) | 102.08% | |||
| EPS Diluted (TTM) | 3.66 | |||
| EPS Diluted Growth (Q YOY) | 105.63% | |||
| Balance Sheet | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 290.00M | |||
| Cash Per Share (Q) | $2.33 | |||
| Total Current Assets (Q) | 1.63B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 121.00M | |||
| Current Ratio (Q) | 0.943 | |||
| Book Value Per Share (Q) | -$0.33 | |||
| Total Assets (Q) | 5.58B | |||
| Total Current Liabilities (Q) | 1.73B | |||
| Total Debt (Q) | 3.09B | |||
| Total Liabilities (Q) | 5.46B | |||
| Total Common Equity (Q) | -41.00M | |||
| Cash Flow | CLX - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -84.00M | |||
| Cash from Financing (TTM) | -897.00M | |||
| Net Change in Cash (TTM) | -64.00M | |||
| Levered Free Cash Flow (TTM) | 507.00M | |||
| Cash from Operations (TTM) | 923.00M | |||
